116 related articles for article (PubMed ID: 22106461)
1. Evaluation of value-based insurance design with a large retail employer.
Kim YA; Loucks A; Yokoyama G; Lightwood J; Rascate K; Serxner SA
Am J Manag Care; 2011 Oct; 17(10):682-90. PubMed ID: 22106461
[TBL] [Abstract][Full Text] [Related]
2. Health care costs and medication adherence associated with initiation of insulin pen therapy in Medicaid-enrolled patients with type 2 diabetes: a retrospective database analysis.
Pawaskar MD; Camacho FT; Anderson RT; Cobden D; Joshi AV; Balkrishnan R
Clin Ther; 2007 Jun; 29(6 Pt 1):1294-305. PubMed ID: 18036391
[TBL] [Abstract][Full Text] [Related]
3. Healthcare utilization and costs of patients with rosacea in an insured population.
Romanowicz M; Stephenson JJ; Del Rosso JQ; Lenhart G
J Drugs Dermatol; 2008 Jan; 7(1):41-9. PubMed ID: 18246697
[TBL] [Abstract][Full Text] [Related]
4. Comparison of real-world adherence, healthcare resource utilization and costs for newly initiated valsartan/amlodipine single-pill combination versus angiotensin receptor blocker/calcium channel blocker free-combination therapy.
Baser O; Andrews LM; Wang L; Xie L
J Med Econ; 2011; 14(5):576-83. PubMed ID: 21728914
[TBL] [Abstract][Full Text] [Related]
5. The impact of a value-based insurance design plus health coaching on medication adherence and medical spending.
Musich S; Wang S; Hawkins K
Popul Health Manag; 2015 Jun; 18(3):151-8. PubMed ID: 25247449
[TBL] [Abstract][Full Text] [Related]
6. Evaluation of increased adherence and cost savings of an employer value-based benefits program targeting generic antihyperlipidemic and antidiabetic medications.
Clark B; DuChane J; Hou J; Rubinstein E; McMurray J; Duncan I
J Manag Care Pharm; 2014 Feb; 20(2):141-50. PubMed ID: 24456315
[TBL] [Abstract][Full Text] [Related]
7. Medical utilization and costs associated with statin adherence in Medicaid enrollees with type 2 diabetes.
Wu J; Seiber E; Lacombe VA; Nahata MC; Balkrishnan R
Ann Pharmacother; 2011 Mar; 45(3):342-9. PubMed ID: 21325098
[TBL] [Abstract][Full Text] [Related]
8. Impact of antidepressant drug adherence on comorbid medication use and resource utilization.
Katon W; Cantrell CR; Sokol MC; Chiao E; Gdovin JM
Arch Intern Med; 2005 Nov; 165(21):2497-503. PubMed ID: 16314547
[TBL] [Abstract][Full Text] [Related]
9. A value-based insurance design program at a large company boosted medication adherence for employees with chronic illnesses.
Gibson TB; Wang S; Kelly E; Brown C; Turner C; Frech-Tamas F; Doyle J; Mauceri E
Health Aff (Millwood); 2011 Jan; 30(1):109-17. PubMed ID: 21209446
[TBL] [Abstract][Full Text] [Related]
10. Costs and utilization associated with pharmaceutical adherence in a diabetic population.
Hepke KL; Martus MT; Share DA
Am J Manag Care; 2004 Feb; 10(2 Pt 2):144-51. PubMed ID: 15005507
[TBL] [Abstract][Full Text] [Related]
11. Cost of diabetes: comparison of disease-attributable and matched cohort cost estimation methods.
Tunceli O; Wade R; Gu T; Bouchard JR; Aagren M; Luo W
Curr Med Res Opin; 2010 Aug; 26(8):1827-34. PubMed ID: 20491613
[TBL] [Abstract][Full Text] [Related]
12. Retrospective claims database analysis to determine relationship between renin-angiotensin system agents, rehospitalization, and health care costs in patients with heart failure or myocardial infarction.
Sun SX; Ye X; Lee KY; Dupclay L; Plauschinat C
Clin Ther; 2008; 30 Pt 2():2217-27. PubMed ID: 19281916
[TBL] [Abstract][Full Text] [Related]
13. Effect of antihypertensive medication adherence among employees with hypertension.
Lynch WD; Markosyan K; Melkonian AK; Pesa J; Kleinman NL
Am J Manag Care; 2009 Dec; 15(12):871-80. PubMed ID: 20001168
[TBL] [Abstract][Full Text] [Related]
14. Evaluation of healthcare utilization and health status of patients with Parkinson's disease treated with deep brain stimulation of the subthalamic nucleus.
Spottke EA; Volkmann J; Lorenz D; Krack P; Smala AM; Sturm V; Gerstner A; Berger K; Hellwig D; Deuschl G; Freund HJ; Oertel WH; Dodel RC
J Neurol; 2002 Jun; 249(6):759-66. PubMed ID: 12111311
[TBL] [Abstract][Full Text] [Related]
15. The effect of a large regional health plan's value-based insurance design program on statin use.
Frank MB; Fendrick AM; He Y; Zbrozek A; Holtz N; Leung S; Chernew ME
Med Care; 2012 Nov; 50(11):934-9. PubMed ID: 23047782
[TBL] [Abstract][Full Text] [Related]
16. Mail-order pharmacy use and medication adherence among Medicare Part D beneficiaries with diabetes.
Zhang L; Zakharyan A; Stockl KM; Harada AS; Curtis BS; Solow BK
J Med Econ; 2011; 14(5):562-7. PubMed ID: 21728913
[TBL] [Abstract][Full Text] [Related]
17. Healthcare costs and nonadherence among chronic opioid users.
Leider HL; Dhaliwal J; Davis EJ; Kulakodlu M; Buikema AR
Am J Manag Care; 2011 Jan; 17(1):32-40. PubMed ID: 21348566
[TBL] [Abstract][Full Text] [Related]
18. Cost of post-traumatic stress disorder vs major depressive disorder among patients covered by medicaid or private insurance.
Ivanova JI; Birnbaum HG; Chen L; Duhig AM; Dayoub EJ; Kantor ES; Schiller MB; Phillips GA
Am J Manag Care; 2011 Aug; 17(8):e314-23. PubMed ID: 21851139
[TBL] [Abstract][Full Text] [Related]
19. Antihypertensive medication adherence and subsequent healthcare utilization and costs.
Pittman DG; Tao Z; Chen W; Stettin GD
Am J Manag Care; 2010 Aug; 16(8):568-76. PubMed ID: 20712390
[TBL] [Abstract][Full Text] [Related]
20. Outcomes and lessons learned from evaluating TRICARE's disease management programs.
Dall TM; Askarinam Wagner RC; Zhang Y; Yang W; Arday DR; Gantt CJ
Am J Manag Care; 2010 Jun; 16(6):438-46. PubMed ID: 20560687
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
